FBRX

Forte Biosciences Inc

NASDAQ: FBRX · HEALTHCARE · BIOTECHNOLOGY

$76.98

+0.59% today

Updated 2026-07-30

Market cap

$1.12B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.20

Dividend yield

—

52W range

$9 – $62

Volume

1.1M

Market cap

$1.12B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.20

Dividend yield

—

52W range

$9 – $62

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.3

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-4.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$66.60

-13.48%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -3.96 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-18.81M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-13.86M	$-31.48M	$-35.48M	$-69.38M	$-22.14M
EPS	—	—	—	—	$-4.20
Free cash flow	$-8.19M	$-28.79M	$-30.78M	$-51.00M	$-18.81M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-07-01	WAGNER, PAUL A.	Sale	1,250	—
2026-07-01	WAGNER, PAUL A.	Buy	1,250	—
2026-07-01	WAGNER, PAUL A.	Sale	98	$21.32

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FBRX	$1.12B	23	4.3	3.0	5.0	4.3	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Forte Biosciences Inc trades at $76.98. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -3.96, it sits in the distress.

Frequently asked questions

What is Forte Biosciences Inc's stock price?

Forte Biosciences Inc (FBRX) trades at $76.98.

Is Forte Biosciences Inc overvalued?

Forte Biosciences Inc carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Forte Biosciences Inc (FBRX)?

The 12-month analyst consensus target is $66.60, about 13.5% below the current $76.98. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Forte Biosciences Inc's Altman Z-Score is -3.96, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-180.18%

Beta2.84

50D MA$26.41

200D MA$24.86

Shares out0.02B

Float0.02B

Short ratio—

Avg volume1.1M

Performance

1 week+12.12%

1 month+192.78%

3 months+99.56%

YTD+100.88%

1 year—

3 years—

5 years—

Compare

FBRX vs LLY →FBRX vs JNJ →FBRX vs ABBV →Stock screener →